CTRI/2024/07/071146尚未招募2 期
An Open Labelled Comparative Clinical Study to Evaluate the Efficacy of Bharangyadi Madhuka and Talishadi Churna in the Management of Tamaka Shwas with special Reference to Bronchial Asthma - NI
Institute For Ayurved Studies and Research0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1 Patient willing for clinical trial and ready to give written Consent.
- •2 Patient between the age group of 25-60 years of either sex.
- •3 Patients fulfill the diagnostic criteria of Tamaka Shwasa (Bronchial Asthma).
- •4 Patients presented with cardinal features of Tamaka Shwasa as described in Ayurveda texts.
- •5 Diagnosed and confirmed cases of Tamaka Shawasa (Bronchial Asthma) on the basis of criteria given by NAEPP having Mild Intermittent and Mild Persistent type of Asthma
排除标准
- •1 Patient not willing to Clinical Trial
- •2 Patients not fulfilling the Inclusion Criteria.
- •3 Patient having an Age below 25 and Above 60.
- •4 Patients having a medical history of CHF, CAD, Pulmonary hypertension, Diabetes Mellitus, Uncontrolled hypertension, CKD, and Autoimmune disorders.
- •5 During Pregnancy, Lactation period
- •6 Patients on Steroid therapy, Inhaler.
- •7 Patient Suffering from Secondary Respiratory Disease
研究者
相似试验
尚未招募
2 期
Ayurvedic intervention in Menstrual DisorderCTRI/2024/04/066545Parul Institute of Ayurved
已完成
1 期
Ayurvedic treatment of near nearsightedness (a refractive error)CTRI/2019/09/021269Department of Shalakya Tantra40
进行中(未招募)
1 期
Dermatitis StudyEUCTR2017-001574-42-Outside-EU/EEAGlaxoSmithKline Research & Development Ltd123
已完成
3 期
A clinical trial to study the effects of Recombinant Human Erythropoietin therapy in management of anemia in patients suffering from Chronic Renal Failure.CTRI/2009/091/000786upin Limited India
已完成
3 期
A randomized, open-label, comparative trial to evaluate the effects on ovarian function of a monophasic combined oral contraceptive (COC) containing 2.5 mg nomegestrol acetate (NOMAC) and 1.5 mg estradiol (E2), compared to a monophasic COC containing 3 mg drospirenone (DRSP) and 30 µg ethinyl estradiol (EE).NL-OMON29993Organon Nederland BV48
